Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Pei Hung

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Materials Science & Engineering. C, Materials for Biological Applications|January 13, 2015
Nanoscale crystallinity modulates cell proliferation on plasma sprayed surfacesAlan M Smith, Jennifer Z Paxton, Yi-Pei Hung, et al.
Current Issues in Molecular Biology|August 28, 2024
ELIXCYTE<sup>®</sup>, an Allogenic Adipose-Derived Stem Cell Product, Mitigates Osteoarthritis by Reducing Inflammation and Preventing Cartilage Degradation In VitroYu-Hsiu Chen, Yi-Pei Hung, Chih-Ying Chen, et al.
Stem Cells Translational Medicine|January 20, 2026
Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II studyYi-Chun Lin, Yi-Pei Hung, Ya-Chung Tian, et al.
Stem Cell Research & Therapy|October 31, 2021
Treatment of knee osteoarthritis with intra-articular injection of allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE®: a phase I/II, randomized, active-control, single-blind, multiple-center clinical trialCheng-Fong Chen, Chih-Chien Hu, Chen-Te Wu, et al.
Clinical and Translational Science|November 27, 2025
Real-World Data as External Control in Assessing the Efficacy of Allogeneic Adipose-Derived Stem Cells Therapy for Advanced Chronic Kidney DiseaseYi-Chun Lin, Yi-Pei Hung, Ya-Chung Tian, et al.
Frontiers in Endocrinology|June 9, 2023
A novel therapeutic approach for endometriosis using adipose-derived stem cell-derived conditioned medium- A new hope for endometriotic patients in improving fertilityS Joseph Huang, Chun-Yen Huang, Yu-Hao Huang, et al.
Journal of Cellular and Molecular Medicine|April 13, 2022
Allogeneic adipose tissue-derived stem cells ELIXCYTE<sup>®</sup> in chronic kidney disease: A phase I study assessing safety and clinical feasibilityCai-Mei Zheng, I-Jen Chiu, Yu-Wei Chen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Materials Science & Engineering. C, Materials for Biological Applications|January 13, 2015
Nanoscale crystallinity modulates cell proliferation on plasma sprayed surfacesAlan M Smith, Jennifer Z Paxton, Yi-Pei Hung, et al.
Current Issues in Molecular Biology|August 28, 2024
ELIXCYTE<sup>®</sup>, an Allogenic Adipose-Derived Stem Cell Product, Mitigates Osteoarthritis by Reducing Inflammation and Preventing Cartilage Degradation In VitroYu-Hsiu Chen, Yi-Pei Hung, Chih-Ying Chen, et al.
Stem Cells Translational Medicine|January 20, 2026
Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II studyYi-Chun Lin, Yi-Pei Hung, Ya-Chung Tian, et al.
Stem Cell Research & Therapy|October 31, 2021
Treatment of knee osteoarthritis with intra-articular injection of allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE®: a phase I/II, randomized, active-control, single-blind, multiple-center clinical trialCheng-Fong Chen, Chih-Chien Hu, Chen-Te Wu, et al.
Clinical and Translational Science|November 27, 2025
Real-World Data as External Control in Assessing the Efficacy of Allogeneic Adipose-Derived Stem Cells Therapy for Advanced Chronic Kidney DiseaseYi-Chun Lin, Yi-Pei Hung, Ya-Chung Tian, et al.
Frontiers in Endocrinology|June 9, 2023
A novel therapeutic approach for endometriosis using adipose-derived stem cell-derived conditioned medium- A new hope for endometriotic patients in improving fertilityS Joseph Huang, Chun-Yen Huang, Yu-Hao Huang, et al.
Journal of Cellular and Molecular Medicine|April 13, 2022
Allogeneic adipose tissue-derived stem cells ELIXCYTE<sup>®</sup> in chronic kidney disease: A phase I study assessing safety and clinical feasibilityCai-Mei Zheng, I-Jen Chiu, Yu-Wei Chen, et al.
Pageof 1